Endometrial cancer secondary prevention: Difference between revisions
YazanDaaboul (talk | contribs) |
YazanDaaboul (talk | contribs) |
||
| Line 16: | Line 16: | ||
:* Pelvic examination | :* Pelvic examination | ||
::* Inguinal nodes | ::* Inguinal nodes | ||
::* [[Pap test]] to | ::* [[Pap test]] to detect cancer cells in the upper vagina | ||
3. The following test are recommended to check for recurrence: | 3. The following test are recommended to check for recurrence: | ||
:* [[Chest x-ray]] may be done yearly | :* [[Chest x-ray]] may be done yearly | ||
Revision as of 16:38, 28 September 2015
|
Endometrial cancer Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Endometrial cancer secondary prevention On the Web |
|
American Roentgen Ray Society Images of Endometrial cancer secondary prevention |
|
Risk calculators and risk factors for Endometrial cancer secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Monalisa Dmello, M.B,B.S., M.D. [2]
Overview
The risk of recurrence of endometrial cancer is highest within 2 years. Life-time follow-up is needed, especially within the first 2 years following diagnosis and successful treatment. Routine follow-up visists occur at 3-4 months interval during the first 2 years, at 6 months interval during the next 3 years, and yearly thereafter.
Secondary Prevention
The risk of recurrence of endometrial cancer is highest within 2 years. Life-time follow-up is needed, especially within the first 2 years following diagnosis and successful treatment.[1]
1. Follow-up visits are routinely scheduled as shown below:
- Every 3–4 months during the first 2 years
- Every 6 months during the next 3 years
- Yearly thereafter
2. Follow-up visit includes:
- Complete physical examination
- Pelvic examination
- Inguinal nodes
- Pap test to detect cancer cells in the upper vagina
3. The following test are recommended to check for recurrence:
- Chest x-ray may be done yearly
- CT scan may be done if the woman has symptoms or something is found during the examination
- Serum concentration of cancer antigen 125 (CA125) may be checked for abrupt elevations
4. If a recurrence is detected during follow-up, a thorough oncological reassessment is required for adequate management.
References
- ↑ Follow-up after treatment for uterine cancer. Canadian Cancer Society. http://www.cancer.ca/en/cancer-information/cancer-type/uterine/treatment/follow-up/?region=ns. URL Accessed on September, 22 2015